Welcome to this episode of the VJNeurology Podcast, where leading experts will explore some of the latest advances in the treatment of myasthenia gravis, discussing emerging therapeutic strategies and new clinical data that could shape the future management of this condition. You’ll hear about recently approved therapies, including inebilizumab and nipocalimab, as well as promising approaches still in development, such as CAR T-cell therapy and telitacicept.

Featuring Richard Nowak, MD, MS, Yale School of Medicine, New Haven, CT, and Ali Habib, MD, University of California, Irvine, CA.